NCT03800550View on ClinicalTrials.gov

A Study to Assess the Drug-Drug Interaction Between Bedaquiline and Clarithromycin in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 13, 2019

Primary Completion Date

June 4, 2019

Study Completion Date

June 4, 2019

Conditions
Healthy
Interventions
DRUG

Bedaquiline

Bedaquiline tablet will be administered, orally.

DRUG

Clarithromycin

Clarithromycin tablet will be administered, orally.

Trial Locations (1)

2060

SGS Life Science Services, Antwerp

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT03800550 - A Study to Assess the Drug-Drug Interaction Between Bedaquiline and Clarithromycin in Healthy Adult Participants | Biotech Hunter | Biotech Hunter